Trial Profile
No advantage to rhBMP-2 in addition to autogenous graft for fracture nonunion.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Dibotermin alfa (Primary)
- Indications Non-union fracture
- Focus Therapeutic Use
- 23 Dec 2015 New trial record